about
Semaphorins and neuropilins: new players in the neuroendocrine control of the intrathymic T-cell migration in humansCombinatorial peptide libraries: mining for cell-binding peptides.A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma.Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a Toll-like receptor 2-mediated cell-penetrating peptide.Tumor-penetrating peptides.Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells.A novel peptide specifically targeting ovarian cancer identified by in vivo phage display.Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.Neuropilin-1 expression characterizes T follicular helper (Tfh) cells activated during B cell differentiation in human secondary lymphoid organs.Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastomaWhat role for angiogenesis in childhood acute lymphoblastic leukaemia?Ligand-targeted theranostic nanomedicines against cancerTumor penetrating peptides for improved drug delivery.Tumor-targeting peptides from combinatorial libraries.Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors.Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420Metacaspase-binding peptide inhibits heat shock-induced death in Leishmania (L.) amazonensisNeuropilin signalling in angiogenesis.Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity.Targeted drug delivery for cancer therapy: the other side of antibodies.Neuropilins: a new target for cancer therapy.The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.Neuropilin-1 as Therapeutic Target for Malignant Melanoma.Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics.Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.Semaphorins and neuropilins expression in salivary gland tumors.The CNGRC-GG-D(KLAKLAK)2 peptide induces a caspase-independent, Ca2+-dependent death in human leukemic myeloid cells by targeting surface aminopeptidase N/CD13Prognostic Impact of Neuropilin-1 Expression in Egyptian Children with B-lineage Acute Lymphoblastic Leukemia.Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.
P2860
Q26865237-73495C46-7813-4D74-82BD-E323AC48B82DQ31144876-5F8D3F92-A65B-4CEF-A99E-86236CFAA59EQ33858517-9438444E-41CE-4292-B9D6-55B7A6E354B6Q34818576-2303847C-3B3C-4501-BF6D-A38632EC73C2Q34976054-1C2CE5C0-6F60-4C52-97F1-32B659D60CDCQ35010086-D5DE4CEE-0E34-4496-A3EF-05A875A5E8DEQ35012239-01C1EE61-531F-4FA7-82EE-8DFB6339F907Q35049970-5D933861-AA2C-4BBA-B8BC-FCD8AB0000EFQ35081201-CACAE68A-8A90-4FB1-A210-6A3CDD0EE9C2Q35409649-BBBA48C9-4C98-4997-AD68-327AC9B0C5EDQ35550914-F40E34A2-E390-46B3-8102-09BAB5845A15Q35895637-78EF21EE-37B6-4544-AF06-30351BF858DBQ35978545-F956FF27-4D1F-493B-A59A-F0F462DEAD2AQ36025723-70963207-EE5D-4C1D-9905-116822D4A2D1Q36392586-FDCA95FD-6240-4852-AFAF-602A8DB0F237Q36489958-0E02A09C-C0CB-4D4B-9A0D-E33CF164B0FCQ36960552-EA91125F-B88D-48F6-BE81-7E2831EA91B2Q37745497-01E79355-0C59-43E3-B63E-16CFA8F08CFCQ37977161-A21578C5-AB95-4FDD-9643-F73D253A77E7Q38022543-1A0C67BF-8C16-415B-85C3-4DDC38457494Q38040614-07DC9C18-122E-4194-93B7-2B09E686FB77Q38058816-B947CF8D-CE42-42A8-BA7E-ED2F4C43886FQ38161356-5B7F09DB-44BB-4303-9408-A752ABFD12E0Q38256958-99271247-5179-4106-865E-B9D378A1530BQ38532037-BDD994E0-4872-4036-9BBA-AB5B87939540Q38564219-3D2E6D29-56CF-4B9B-A997-332DAA10C395Q38794978-0F58B378-78AE-4C4F-BCEA-818F7920247AQ38802167-8828C87B-0E0C-44FB-9615-291A32A27283Q39426973-F6A905DE-18C1-43A6-AC7A-8FA07DAC579FQ40298855-9B2F80FF-8D4C-47A3-AE26-0D4830990D37Q41537899-B6752590-4D5D-4D51-A953-E2937BC48245Q43090772-A53E14D0-E3BD-419B-BE6A-CD15E20D6730Q47330613-8B16DB1A-9320-4280-8846-E98B6852B3DB
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Targeting neuropilin-1 in human leukemia and lymphoma
@ast
Targeting neuropilin-1 in human leukemia and lymphoma
@en
Targeting neuropilin-1 in human leukemia and lymphoma
@nl
type
label
Targeting neuropilin-1 in human leukemia and lymphoma
@ast
Targeting neuropilin-1 in human leukemia and lymphoma
@en
Targeting neuropilin-1 in human leukemia and lymphoma
@nl
prefLabel
Targeting neuropilin-1 in human leukemia and lymphoma
@ast
Targeting neuropilin-1 in human leukemia and lymphoma
@en
Targeting neuropilin-1 in human leukemia and lymphoma
@nl
P2093
P2860
P50
P1433
P1476
Targeting neuropilin-1 in human leukemia and lymphoma
@en
P2093
Akihiko Kuniyasu
Amado J Zurita
Bedrich L Eckhardt
Benjamin Lichtiger
Carlos E Bueso-Ramos
Diana E Jaalouk
Frank C Marini
Katja Karjalainen
Wadih Arap
P2860
P356
10.1182/BLOOD-2010-05-282921
P407
P577
2011-01-20T00:00:00Z